For immediate release: September 7, 2008
Boston, MA – Researchers at the Harvard School of Public Health (HSPH) and their collaborators at Tufts University and the National Cancer Institute (NCI) have identified a common genetic influence on B12 vitamin levels in the blood, suggesting a new way to approach the biological connections between an important biochemical variable and deficiency-related diseases.
“The news here is the discovery of a robust genetic predictor of vitamin B12 levels,” said David Hunter, the Vincent L. Gregory Professor of Cancer Prevention and director of the Program in Molecular and Genetic Epidemiology at HSPH and senior author of the study. “This is an example of the way we’re going to understand more about how levels of vitamins and other nutrients in the body are partially determined by genetic factors as well as by what we eat.”
Other studies have found rare gene mutations with dramatic effects on people’s ability to digest, absorb, and use vitamin B12. This paper found more common variations of a gene that has a much smaller effect by itself, but it may belong to an important biological pathway whose careful study may lead to clinically useful strategies and therapeutic intervention.
The researchers first found the gene, called FUT2, in a genome-wide scan of 1,658 women of European ancestry who participated in the Cancer Genetic Markers of Susceptibility (CGEMS) project. They replicated the findings in another 1,059 women from the Nurses’ Health Study.
“This provides a framework for further nutrigenomics studies and for exploring gene-diet interactions with cancer and other diseases,” said Aditi Hazra, HSPH instructor and lead author of the study. The paper was published in the Sept. 7 advance online Nature Genetics.
Other studies have linked B12 deficiency with pernicious anemia, cardiovascular disease, cancer, and neurodegenerative disorders. Lower B12 levels have been associated with cognitive impairment. A key player in the B-vitamin pathway, B12 helps maintain healthy nerve cells, form red blood cells, and synthesize DNA.
In the diet, B12 comes from meat, fish, dairy, other animal products, and fortified breakfast cereals. As many as one-quarter of the elderly may have mild B12 deficiency. Strict vegetarians, who avoid meat, and vegans, who avoid all animal products, are also at risk of B12 deficiency.
“This is an unexpected finding. We thought we had already learned everything about the absorption of vitamin B12,” said co-author Jacob Selhub, director of the Vitamin Metabolism Laboratory at the USDA Human Nutrition Research Center on Aging at Tufts University. He has conducted many of the studies linking B12 status in the elderly with cognitive impairment, anemia, and bone marrow density and osteoporosis.
Anything in the stomach that affects the normal acidity and digestive processes, ranging from infections to acid reflux medicine to aging, may also interfere with B12 absorption, studies suggest. B12 is first separated from food by stomach acid and then escorted from there by a protein called intrinsic factor to the small intestine, where the complex is absorbed and B12 is released into the blood.
Until further studies are conducted, the most plausible explanation is the potential preventive effect of the gene variant on factors known to cause B12 malabsorption, such as H. pylori infection, the researchers say.
Hazra and her colleagues had been investigating the genetic and epigenetic links between colorectal cancer and adenoma and the B-vitamin pathway, also known as the one-carbon metabolism pathway, including folate, vitamins B6 and B12, and homocysteine. Ultimately, she hopes to identify different gene variants that work together and create a nutrigenomics predictor score to assist in future individual cancer prevention strategies.
Evaluating more than 528,000 genetic variants, the strongest signals came from variants in FUT2. The gene variant associated with the highest B12 levels has previously been determined to protect the stomach from infection by the Norwalk virus and ulcer-causing H. pylori bacterium.
In the study, the FUT2 genetic variant accounted for about three percent of the variation in B12 plasma levels, Hazra said. The researchers do not have direct evidence that people who carry the gene variant suffer from any cognitive or other adverse affects of low B12 levels.
This study was supported by the National Cancer Institute of the National Institutes of Health.
Co-authors of this study include Aditi Hazra, Peter Kraft, Edward L. Giovannucci, and David J. Hunter of HSPH; Jacob Selhub of Tufts University; and Gilles Thomas, Robert N. Hoover, Stephen J. Chanock of NCI.
“Common Variants of FUT2 are Associated with Plasma Vitamin B12 Levels,” Hazra et al., Nature Genetics Advance Online publication, Sept. 7, 2008, doi:10.1038/ng.210.
For more information, contact:
Harvard School of Public Health is dedicated to advancing the public’s health through learning, discovery, and communication. More than 400 faculty members are engaged in teaching and training the 1,000-plus student body in a broad spectrum of disciplines crucial to the health and well being of individuals and populations around the world. Programs and projects range from the molecular biology of AIDS vaccines to the epidemiology of cancer; from risk analysis to violence prevention; from maternal and children’s health to quality of care measurement; from health care management to international health and human rights.